交易中 08-10 11:29:55 美东时间
+0.170
+0.88%
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
BTIG analyst Vincent Caintic reiterates Happen (NASDAQ:HAPN) with a Buy and maintains $25 price target.
07-28 17:53
Happen (NASDAQ:HAPN) is looking for FY2026 GAAP EPS of $1.80-$1.90 vs $1.74 analyst estimate..
07-28 04:38
今日重点评级关注:Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元;康托·菲茨杰拉德:维持BioCryst制药"超配"评级,目标价从27美元升至29美元
07-01 10:40
BTIG analyst Vincent Caintic maintains Happen (NASDAQ:HAPN) with a Buy and raises the price target from $20 to $25.
06-30 18:10
Begins trading on Nasdaq under the ticker symbol "HAPN" SAN FRANCISCO, June 22, 2026 /PRNewswire/ -- Happen, Inc. (Nasdaq: HAPN) https://www.multivu.com/lending-club/9384851-en-lendingclub-b...
06-22 21:05